This event has already occurred.

Atique Ahmed, PhD

Atique Ahmed, PhD

Neural Stem Cell-Based Virotherapy for Malignant Glioma


October 31, 2011, 4:00 p.m. to 5:00 p.m.


Atique Ahmed, PhD

Senior Research Associate, Department of Surgery, Section of Neurosurgery, University of Chicago, Chicago, Illinois


Fralin Biomedical Research Institute, R1059
2 Riverside Circle, Roanoke, VA 24016

Oncolytic virotherapy for cancer is a novel approach in which viruses are modified to preferentially replicate in the tumor and destroy it. Dr. Ahmed has been interested in the development of novel viral vectors to target human brain tumors. The clinical application of most current viral vector-based anti-cancer therapeutics is limited by the host antiviral immune response and its inability to target disseminated tumor burdens. The discovery of the inherent tumor-tropic properties of stem cells has provided a unique opportunity to develop cell-based targeted therapies. Dr. Ahmed will present his current work in establishing neural stem cells as a cellular delivery vehicle for anti-glioma oncolytic virotherapy. He will also share his experience with conducting FDA-directed preclinical studies in order to secure an Investigational New Drug application for a phase I clinical trial involving patients with invasive glioblastoma.

Selected Publications

About the Speaker:

Atique Ahmed's research focuses on the development of novel oncolytic viruses for anti-cancer therapy; cell based targeted therapies for malignant brain tumors.

Additional Details

This is a free event. The host is Michael Friedlander, PhD. For more information, please call 540-526-2070, or send an e-mail.

Map and Parking

This map shows where the Fralin Biomedical Research Institute is located in Roanoke, VA at 2 Riverside Circle.

Parking is available in the parking garage across the street.

Click the "Google" logo for a larger version.

Event Type